|
參 考 文 獻
Adler, S., and Brady, H. R. (1999). Cell adhesion molecules and the glomerulopathies. Am J Med 107, 371-386. Agarwal, A., Balla, J., Alam, J., Croatt, A. J., and Nath, K. A. (1995). Induction of heme oxygenase in toxic renal injury: a protective role in cisplatin nephrotoxicity in the rat. Kidney Int 48, 1298-1307. Baeuerle, P. A., and Baltimore, D. (1996). NF-kappa B: ten years after. Cell 87, 13-20. Brown, K., Gerstberger, S., Carlson, L., Franzoso, G., and Siebenlist, U. (1995). Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267, 1485-1488. Burnouf, C., and Pruniaux, M. P. (2002). Recent advances in PDE4 inhibitors as immunoregulators and anti-inflammatory drugs. Curr Pharm Des 8, 1255-1296. Camara, S., de la Cruz, J. P., Frutos, M. A., Sanchez, P., Lopez de Novales, E., Sanchez, E., and Sanchez de la Cuesta, F. (1991). Effects of dipyridamole on the short-term evolution of glomerulonephritis. Nephron 58, 13-16. Choi, A. M., and Alam, J. (1996). Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am J Respir Cell Mol Biol 15, 9-19. Datta, P. K., Koukouritaki, S. B., Hopp, K. A., and Lianos, E. A. (1999). Heme oxygenase-1 induction attenuates inducible nitric oxide synthase expression and proteinuria in glomerulonephritis. J Am Soc Nephrol 10, 2540-2550. Denhardt, D. T., and Guo, X. (1993). Osteopontin: a protein with diverse functions. Faseb J 7, 1475-1482. Engelbrecht, Y., de Wet, H., Horsch, K., Langeveldt, C. R., Hough, F. S., and Hulley, P. A. (2003). Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines. Endocrinology 144, 412-422. FitzGerald, G. A. (1987). Dipyridamole. N Engl J Med 316, 1247-1257. Gaertner, S. A., Janssen, U., Ostendorf, T., Koch, K. M., Floege, J., and Gwinner, W. (2002). Glomerular oxidative and antioxidative systems in experimental mesangioproliferative glomerulonephritis. J Am Soc Nephrol 13, 2930-2937. Gauer, S., Yao, J., Schoecklmann, H. O., and Sterzel, R. B. (1997). Adhesion molecules in the glomerular mesangium. Kidney Int 51, 1447-1453. Gibbs, C. R., and Lip, G. Y. (1998). Do we still need dipyridamole? Br J Clin Pharmacol 45, 323-328. Giembycz, M. A. (2000). Phosphodiesterase 4 inhibitors and the treatment of asthma: where are we now and where do we go from here? Drugs 59, 193-212. Haas, C. S., Schocklmann, H. O., Lang, S., Kralewski, M., and Sterzel, R. B. (1999). Regulatory mechanism in glomerular mesangial cell proliferation. J Nephrol 12, 405-415. Haberstroh, U., Pocock, J., Gomez-Guerrero, C., Helmchen, U., Hamann, A., Gutierrez-Ramos, J. C., Stahl, R. A., and Thaiss, F. (2002). Expression of the chemokines MCP-1/CCL2 and RANTES/CCL5 is differentially regulated by infiltrating inflammatory cells. Kidney Int 62, 1264-1276. Harmankaya, O., Basturk, T., Ozturk, Y., Karabiber, N., and Obek, A. (2001). Effect of acetylsalicylic acid and dipyridamole in primary membranoproliferative glomerulonephritis type I. Int Urol Nephrol 33, 583-587. Hewitson, T. D., Tait, M. G., Kelynack, K. J., Martic, M., and Becker, G. J. (2002). Dipyridamole inhibits in vitro renal fibroblast proliferation and collagen synthesis. J Lab Clin Med 140, 199-208. Hung, K. Y., Shyu, R. S., Fang, C. C., Tsai, C. C., Lee, P. H., Tsai, T. J., and Hsieh, B. S. (2001). Dipyridamole inhibits human peritoneal mesothelial cell proliferation in vitro and attenuates rat peritoneal fibrosis in vivo. Kidney Int 59, 2316-2324. Jefferson, J. A., and Johnson, R. J. (1999). Experimental mesangial proliferative glomerulonephritis (the anti-Thy-1.1 model). J Nephrol 12, 297-307. Juckett, M. B., Balla, J., Balla, G., Jessurun, J., Jacob, H. S., and Vercellotti, G. M. (1995). Ferritin protects endothelial cells from oxidized low density lipoprotein in vitro. Am J Pathol 147, 782-789. Kassel, O., Sancono, A., Kratzschmar, J., Kreft, B., Stassen, M., and Cato, A. C. (2001). Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. Embo J 20, 7108-7116. Klahr, S., Schreiner, G., and Ichikawa, I. (1988). The progression of renal disease. N Engl J Med 318, 1657-1666. Lasa, M., Abraham, S. M., Boucheron, C., Saklatvala, J., and Clark, A. R. (2002). Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol Cell Biol 22, 7802-7811. Lenz, T. L., and Hilleman, D. E. (2000). Aggrenox: a fixed-dose combination of aspirin and dipyridamole. Ann Pharmacother 34, 1283-1290. Liaw, L., Lindner, V., Schwartz, S. M., Chambers, A. F., and Giachelli, C. M. (1995). Osteopontin and beta 3 integrin are coordinately expressed in regenerating endothelium in vivo and stimulate Arg-Gly-Asp-dependent endothelial migration in vitro. Circ Res 77, 665-672. Loher, F., Schmall, K., Freytag, P., Landauer, N., Hallwachs, R., Bauer, C., Siegmund, B., Rieder, F., Lehr, H. A., Dauer, M., et al. (2003). The specific type-4 phosphodiesterase inhibitor mesopram alleviates experimental colitis in mice. J Pharmacol Exp Ther 305, 549-556. Malinin, N. L., Boldin, M. P., Kovalenko, A. V., and Wallach, D. (1997). MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature 385, 540-544. Matsumori, A., Nunokawa, Y., and Sasayama, S. (2000). Pimobendan inhibits the activation of transcription factor NF-kappaB: a mechanism which explains its inhibition of cytokine production and inducible nitric oxide synthase. Life Sci 67, 2513-2519. Mishra, R., Leahy, P., and Simonson, M. S. (2003). Gene expression profile of endothelin-1-induced growth in glomerular mesangial cells. Am J Physiol Cell Physiol 285, C1109-1115. Moncada, S., and Korbut, R. (1978). Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin. Lancet 1, 1286-1289. Morimoto, K., Ohta, K., Yachie, A., Yang, Y., Shimizu, M., Goto, C., Toma, T., Kasahara, Y., Yokoyama, H., Miyata, T., et al. (2001). Cytoprotective role of heme oxygenase (HO)-1 in human kidney with various renal diseases. Kidney Int 60, 1858-1866. Nath, K. A., Balla, G., Vercellotti, G. M., Balla, J., Jacob, H. S., Levitt, M. D., and Rosenberg, M. E. (1992). Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest 90, 267-270. Pichler, R., Giachelli, C. M., Lombardi, D., Pippin, J., Gordon, K., Alpers, C. E., Schwartz, S. M., and Johnson, R. J. (1994). Tubulointerstitial disease in glomerulonephritis. Potential role of osteopontin (uropontin). Am J Pathol 144, 915-926. Rittling, S. R., and Denhardt, D. T. (1999). Osteopontin function in pathology: lessons from osteopontin-deficient mice. Exp Nephrol 7, 103-113. Ruiz-Ortega, M., Lorenzo, O., Ruperez, M., Esteban, V., Mezzano, S., and Egido, J. (2001). Renin-angiotensin system and renal damage: emerging data on angiotensin II as a proinflammatory mediator. Contrib Nephrol, 123-137. Schlondorff, D. (1987). The glomerular mesangial cell: an expanding role for a specialized pericyte. Faseb J 1, 272-281. Schreiner, G. F. (1992). The mesangial phagocyte and its regulation of contractile cell biology. J Am Soc Nephrol 2, S74-82. Segerer, S., Nelson, P. J., and Schlondorff, D. (2000). Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 11, 152-176. Senger, D. R., Perruzzi, C. A., Papadopoulos-Sergiou, A., and Van de Water, L. (1994). Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain. Mol Biol Cell 5, 565-574. Sha, W. C. (1998). Regulation of immune responses by NF-kappa B/Rel transcription factor. J Exp Med 187, 143-146. Shankland, S. J., Hugo, C., Coats, S. R., Nangaku, M., Pichler, R. H., Gordon, K. L., Pippin, J., Roberts, J. M., Couser, W. G., and Johnson, R. J. (1996). Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis. Kidney Int 50, 1230-1239. Shimizu, H., Takahashi, T., Suzuki, T., Yamasaki, A., Fujiwara, T., Odaka, Y., Hirakawa, M., Fujita, H., and Akagi, R. (2000). Protective effect of heme oxygenase induction in ischemic acute renal failure. Crit Care Med 28, 809-817. Singh, R. P., Patarca, R., Schwartz, J., Singh, P., and Cantor, H. (1990). Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo. J Exp Med 171, 1931-1942. Stawowy, P., Goetze, S., Margeta, C., Fleck, E., and Graf, K. (2003). LPS regulate ERK1/2-dependent signaling in cardiac fibroblasts via PKC-mediated MKP-1 induction. Biochem Biophys Res Commun 303, 74-80. Stocker, R. (1990). Induction of haem oxygenase as a defence against oxidative stress. Free Radic Res Commun 9, 101-112. Tang, W. W., Yin, S., Wittwer, A. J., and Qi, M. (1995). Chemokine gene expression in anti-glomerular basement membrane antibody glomerulonephritis. Am J Physiol 269, F323-330. Teixeira, M. M., Gristwood, R. W., Cooper, N., and Hellewell, P. G. (1997). Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future? Trends Pharmacol Sci 18, 164-171. Thom, S. R., Fisher, D., Xu, Y. A., Notarfrancesco, K., and Ischiropoulos, H. (2000). Adaptive responses and apoptosis in endothelial cells exposed to carbon monoxide. Proc Natl Acad Sci U S A 97, 1305-1310. Veis, J. H. (1993). An overview of mesangial cell biology. Contrib Nephrol 104, 115-126. Weber, G. F., and Cantor, H. (1996). The immunology of Eta-1/osteopontin. Cytokine Growth Factor Rev 7, 241-248. Wu, X., Dolecki, G. J., Sherry, B., Zagorski, J., and Lefkowith, J. B. (1997). Chemokines are expressed in a myeloid cell-dependent fashion and mediate distinct functions in immune complex glomerulonephritis in rat. J Immunol 158, 3917-3924. Yu, X. Q., Nikolic-Paterson, D. J., Mu, W., Giachelli, C. M., Atkins, R. C., Johnson, R. J., and Lan, H. Y. (1998). A functional role for osteopontin in experimental crescentic glomerulonephritis in the rat. Proc Assoc Am Physicians 110, 50-64.
|